OP0001

EFFECT OF SECUKINUMAB, AN INTERLEUKIN-17A INHIBITOR, ON SPINAL RADIOGRAPHIC CHANGES THROUGH 2 YEARS IN PATIENTS WITH ACTIVE ANKYLOSING SPONDYLITIS: RESULTS OF THE PHASE 3 STUDY, MEASURE 1

J. Braun^1,*, X. Baraliakos¹, A. Deodhar², D. Baeten ³, J. Sieper⁴, P. Emery⁵, Z. Talloczy⁶, R. Martin⁶, H. B. Richards⁷

¹Rheumazentrum Ruhrgebiet, Herne, Germany, ²Oregon Health & Science University, Portland, United States, ³Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands, ⁴Charité University Medicine Berlin, Berlin, Germany, ⁵Leeds Musculoskeletal Biomedical Research Unit/Institute Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, United Kingdom, ⁶Novartis Pharmaceuticals Corporation, East Hanover, United States, ⁷Novartis Pharma AG, Basel, Switzerland

DOI: 10.1136/annrheumdis-2016-eular.3177